Cell and Gene Therapy

Quarkmed has been deeply engaged in the field of cell and gene therapy (CGT) for many years, and be capable of covering the registration and clinical trial services of the whole process from IND to NDA in the CGT field. In the past few years, Quarkmed has established cooperative relations with more than 100 relevant institutions in CGT field to reduce registration risks, write medical strategies, shorten project cycles, save R&D funds for customers, and contribute to the development of the CGT field from multiple dimensions.

Clinical project experience (including but not limited to):

• Leukemia

• Lymphoma

• Multiple myeloma

• Glioblastoma

• Ovarian cancer

• Pancreatic cancer

• Advanced solid tumor

• Cerebral stroke

• Rh arthritis

• Joint disorder